Department of Pharmaceutical Chemistry

Manglik shares passion for cellular communication in UCSF Byers Award Lecture

Department of Pharmaceutical Chemistry faculty member Aashish Manglik, MD, PhD, was celebrated as a curiosity-driven scientist in the 29th annual Byers Award Lecture, where he shared how he fulfilled a research dream in his journey from Stanford University to UCSF.

Pharma executive with UCSF roots named vice chancellor for business development, innovation, and partnerships

David Morris, MD, has worked with many Bay Area startups, including a spin-off from the lab of Department of Pharmaceutical Chemistry faculty member Jim Wells, PhD.

$25 million federal defense grant funds anesthesia innovation

Department of Pharmaceutical Chemistry faculty members Brian Shoichet, PhD, and Jason Sello, PhD, combine collaboration, curiosity, and innovation to discover molecules that can become anesthetics administered without specialized training.

Kelly Kwan

QBC Programs Assistant

As the QBC Programs Assistant, I support the program managers of the Quantitative Biosciences Consortium graduate programs to ensure their successful operation.

A new vision for the Small Molecule Discovery Center

Charles Hart, PhD, director of the Catalyst Program, joins Department of Pharmaceutical Chemistry Chair Michelle Arkin in the center’s ongoing collaboration with academics, government labs, and pharmaceutical companies to develop drug leads that address unmet medical needs.

School of Pharmacy shows out in Grad Slam storytelling competition

Three students with ties to the School were finalists in the event, which challenges graduate students to explain their research to an audience of non-experts in just three minutes.

School of Pharmacy leads in NIH funding for the 44th straight year

School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.

Manglik awarded 2024 Bowes Biomedical Investigator

The GPCR and neuropsychiatric diseases researcher will receive $1.25 million over five years to explore new territory.

Pages